Iterum Therapeutics Stock Surges 160% Pre-Market

Iterum Therapeutics shares explode 159.55% in pre-market trading amid massive volatility after the biotech firm files for liquidation in Ireland's High Court. The company faces severe financial distress, with a hearing set for April 13, 2026, and Nasdaq trading suspension expected since March 27. CEO and CFO resign as provisional liquidators take control, warning shareholders of potential total loss. Read more about this...